Large pharmaceutical companies say allowing Medicare to negotiate lower drug prices will stifle innovation in drug development. Read a new op-ed in Harvard Business Review to find out why that’s not so.
Timely information on people’s experiences in accessing and affording health care, and research into how public policies affect health insurance coverage and affordability nationally and at the state level.
We track health insurance coverage, affordability, and health outcomes for Black, Latino, Asian, Pacific Islander and Native Americans. We also highlight policies and practices needed to achieve an antiracist health system.